MENU
GNLX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Genelux (GNLX) Earnings Date & Reports

Genelux Corp is a clinical-stage biopharmaceutical company... Show more

A.I. Advisor
published Earnings

GNLX is expected to report earnings to fall 12.00% to -21 cents per share on May 08

Genelux GNLX Stock Earnings Reports
Q1'25
Est.
$-0.22
Q4'24
Est.
$-0.25
Q3'24
Beat
by $0.06
Q2'24
Beat
by $0.02
Q1'24
Missed
by $0.06
The last earnings report on March 28 showed earnings per share of -25 cents, meeting the estimate of -25 cents. With 235.51K shares outstanding, the current market capitalization sits at 95.51M.
View a ticker or compare two or three
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2625 Townsgate Road
Phone
+1 805 267-9889
Employees
23
Web
https://www.genelux.com